The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Current and future ophthalmic drug delivery systems
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Self-citationDUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
DNA-based therapeutics and DNA delivery systems: A comprehensive review
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070109 · Cited by 630
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 589
Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis
Jaffe, G. J., Martin, D., Callanan, D., Pearson, P. A., Levy, B., & Comstock, T. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.021 · Cited by 454
Kuppermann, B. D. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.309 · Cited by 429
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261
Self-citationGold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M., Kontturi, K., & Urtti, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 252
Self-citationIntraocular implants for extended drug delivery: Therapeutic applications
Bourges, J. L., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Behar-Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000038 · Cited by 208
Ideta, R., Tasaka, F., Jang, W.-D., Nishiyama, N., Zhang, G.-D., Harada, A., Yanagi, Y., Tamaki, Y., Aida, T., & Kataoka, K. (2005) · Nano Letters · doi:10.1021/nl051679d · Cited by 196
Applications of Liposomes in Ophthalmology
Ebrahim, S., Peyman, G. A., & Lee, P. J. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2004.12.006 · Cited by 193
Nanoparticles for gene delivery to retinal pigment epithelial cells.
Bejjani, R. A., BenEzra, D., Cohen, H., Rieger, J., Andrieu‐Soler, C., Jeanny, J., Gollomb, G., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 176
MYLES, M., NEUMANN, D., & HILL, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.08.006 · Cited by 171
Marano, R. J., Toth, I., Wimmer, N., Brankov, M., & Rakoczy, P. E. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302579 · Cited by 164
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Ranta, V.-P., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.025 · Cited by 160
Self-citationJang, W., Nakagishi, Y., Nishiyama, N., Kawauchi, S., Morimoto, Y., Kikuchi, M., & Kataoka, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.009 · Cited by 157
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
Fattal, E., & Bochot, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.020 · Cited by 152
Vitreous Is a Barrier in Nonviral Gene Transfer by Cationic Lipids and Polymers
Pitkänen, L., Ruponen, M., Nieminen, J., & Urtti, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1023238530504 · Cited by 134
Self-citationIntraocular sustained drug delivery using implantable polymeric devices
Yasukawa, T., OGURA, Y., Sakurai, E., Tabata, Y., & KIMURA, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.005 · Cited by 133
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
Urtti, A. O., Pipkin, J. D., Rork, G. S., Sendo, T., Finne, U., & Repta, A. J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90215-p · Cited by 121
Self-citationApplication of encapsulated cell technology for retinal degenerative diseases
Tao, W. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.7.717 · Cited by 109
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot, A., Fattal, E., Boutet, V., Deverre, J. R., Jeanny, J., Chacun, H., & Couvreur, P. (2002) · PubMed · Cited by 98
Moshfeghi, A., & Peyman, G. A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.006 · Cited by 98
Drug delivery methods for posterior segment disease
Hsu, J. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3281108000 · Cited by 97
dos Santos, A. L. G., Bochot, A., Doyle, A., Tsapis, N., Siepmann, J., Siepmann, F., Schmaler, J., Besnard, M., Béhar‐Cohen, F., & Fattal, E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.010 · Cited by 96
Saishin, Y., Silva, R. L., Saishin, Y., Callahan, K. P., Schoch, C., Ahlheim, M., Lai, H. C., Kane, F. E., Brazzell, R. K., Bodmer, D., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0600 · Cited by 94
Tolerance of Ocular Iontophoresis in Healthy Volunteers
Parkinson, T. M., Ferguson, E. H., Febbraro, S., Bakhtyari, A., King, M., & Mundasad, M. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637672 · Cited by 91
Novel approaches to ocular drug delivery.
Davis, J. L., Gilger, B. C., & Robinson, M. R. (2004) · PubMed · Cited by 79
Iontophoresis: from the lab to the bed side
Halhal, M., Renard, G. J., Courtois, Y., et al. (2003) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.017 · Cited by 76
Recent developments in ocular gene therapy
Borrás, T. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00030-7 · Cited by 74
Ocular delivery using poly(ortho esters)
Heller, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.007 · Cited by 70
Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant
Kato, A., Kimura, H., Okabe, K., Okabe, J., Kunou, N., & Ogura, Y. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1258 · Cited by 66
PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION: A REVIEW
Woodburn, K. W., Engelman, C. J., & Blumenkranz, M. S. (2002) · Retina · doi:10.1097/00006982-200208000-00001 · Cited by 64
Pitkänen, L., Pelkonen, J., Ruponen, M., Rönkkö, S., & Urtti, A. O. (2004) · The AAPS Journal · doi:10.1208/aapsj060325 · Cited by 61
Self-citationControlled Ocular Timolol Delivery: Systemic Absorption and Intraocular Pressure Effects in Humans
Urtti, A. O., Rouhiainen, H. J., Kaila, T. J., & Saano, V. (1994) · Pharmaceutical Research · doi:10.1023/a:1018938310628 · Cited by 57
Self-citationElectrically Assisted Ocular Gene Therapy
Bejjani, R. A., Andrieu‐Soler, C., Bloquel, C., Berdugo, M., BenEzra, D., & Béhar‐Cohen, F. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.12.005 · Cited by 54
Wimmer, N., Marano, R. J., Kearns, P. S., Rakoczy, E. P., & Tóth, I. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00511-5 · Cited by 50
Molecular targets for retinal vascular diseases
Campochiaro, P. A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20893 · Cited by 41
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand, N., Valamanesh, F., Savoldelli, M., Mascarelli, F., BenEzra, D., Courtois, Y., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 41
Mannermaa, E., Rönkkö, S., Ruponen, M., Reinisalo, M., & Urtti, A. O. (2005) · Current Eye Research · doi:10.1080/02713680590934058 · Cited by 28
Self-citationKahook, M. Y. (2007) · Expert Review of Medical Devices · doi:10.1586/17434440.4.2.261 · Cited by 20
New Drug Delivery for Corneal Neovascularization Using Polyion Complex Micelles
Usui, T., Sugisaki, K., Amano, S., Jang, W., Nishiyama, N., & Kataoka, K. (2005) · Cornea · doi:10.1097/01.ico.0000178738.29459.59 · Cited by 19
Intraocular Delivery of Oligonucleotides
dos Santos, A. L. S., Bochot, A., & Fattal, E. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167239 · Cited by 18
&NA; (2004) · Drugs in R&D · doi:10.2165/00126839-200405010-00013 · Cited by 13
Photodynamic therapy in macular diseases
Ruiz‐Moreno, J. M., & Montero, J. A. (2006) · Expert Review of Ophthalmology · doi:10.1586/17469899.1.1.97 · Cited by 1
Cited by
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Self-citationApplications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
Metadata
- Authors
- del Amo, E. M., & Urtti, A.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 13
- Issue
- 3-4
- Pages
- 135-143
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2055499548
- Cited by
- 414
- References
- 50
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.